Dabigatran, a direct thrombin inhibitor, has robust data for the treatment of deep venous
thrombosis and pulmonary embolism, stroke prevention in non-valvular atrial fibrillation, and …

Background: Direct oral anticoagulants (DOACs) are increasingly used in place of warfarin,
but evidence about their effectiveness and safety in patients with valvular atrial fibrillation …

Cerebral venous thrombosis (CVT) is a rare complication of hypercoagulable states such as
pregnancy, lupus anticoagulant syndrome, systemic lupus erythematosus, Crohn's disease …

Warfarin is one of the most commonly used anticoagulants in the management of
thromboembolic events. Herein we report a rare case of warfarin induced leukocytoclastic …

OBJECTIVES The newest mechanical valves have low thrombogenicity, making them
candidates for anticoagulation with a direct oral anticoagulant. While these drugs hold great …

Objective Anticoagulant and antiplatelet therapy have become increasingly popular. The
goal of therapy is to prevent venous thromboembolism and platelet aggregation …

Warfarin is the standard of care, and direct oral anticoagulants (DOACs) are a group of
newer drugs to prevent stroke in patients with valvular heart disease. The aim of this meta …

Bleeding is the most serious complication of warfarin anticoagulation therapy and is known
to occur even at patients with therapeutic international normalized ratio (INR) range …

Discussion Bioprosthetic valve can fail for a number of reasons including fibrotic pannus
ingrowth, endocarditis, degeneration and thrombosis [15],[16]. Risk factors for BV thrombosis …

Clinicians treating atrial fibrillation must initially identify and ultimately verify whether this
rhythm fits within the definition of “non-valvular” atrial fibrillation (NVAF). The spectrum of …